ReviewFrontiers in cardiovascular medicine2026
Myocardial radiomics of non-ischemic cardiomyopathy using cardiovascular magnetic resonance: current perspectives and future directions.
Review in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Spatiotemporal deep learning for scar screening in cardiovascular magnetic resonance: Toward selective use of gadolinium.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic ResonanceArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Heart failure remains a major source of global morbidity and mortality, frequently driven by the structural and functional myocardial changes associated with ischemic and non-ischemic cardiomyopathies. While cardiovascular magnetic resonance (CMR) is the gold standard for non-invasive ventricular assessment, standard clinical measures rely on visual human interpretation. By contrast, radiomic analysis, a high-throughput computational approach that can extract quantitative features beyond the limits of visual perception, has gained interest in its application to CMR for detailed evaluation of myocardial properties. Over the last decade, novel studies integrating radiomics with machine learning (ML) algorithms may enable more accurate diagnosis and personalized characterization of non-ischemic cardiomyopathy beyond traditional CMR sequences, and without the use of gadolinium-based contrast agents. This review provides an overview of CMR radiomic analysis, summarizes recent applications of ML workflows in non-ischemic cardiomyopathy, and discusses the challenges and opportunities in integrating these computational tools into clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.